Literature DB >> 19421765

Management of postvitrectomy diabetic vitreous hemorrhage with volume homeostatic fluid-fluid exchanger.

Wen-Chuan Wu1, Jen-Yu Chen, Ya-Chi Chen, Yo-Chen Chang.   

Abstract

BACKGROUND: To evaluate the clinical outcome of patients with postvitrectomy diabetic vitreous hemorrhage (PDVH) who underwent vitreous cavity lavage (VL) by volume homeostatic fluid-fluid exchange.
METHODS: We performed a retrospective chart review for 88 eyes of 80 consecutive patients who underwent VL for PDVH. Final best-corrected visual acuity after VL was compared to those before VL. Anatomic outcome, including rate of fundus clear-up, recurrent vitreous hemorrhage, increased intraocular pressure, iris neovacularization and anterior hyaloid fibrovascular proliferation were considered.
RESULTS: Between July 1999 and January 2006, 88 eyes of 80 patients underwent this procedure. Significant visual improvement was observed after VL (2.86 +/- 0.40 logMAR at baseline vs 1.71 +/- 0.97 logMAR at last visit, p < 0.0001). The fundus clear-up rate after VL was achieved in 84 out of 109 times (77.1%). Recurrent vitreous hemorrhage was found in 17 of 88 eyes (19.3%) with the mean interval of 92.6 +/- 126.7 days after VL.
CONCLUSIONS: For patients suffering from postvitrectomy diabetic vitreous hemorrhage, volume homeostatic vitreous cavity lavage can be an alternative method for removing the bloody content in the vitreous cavity efficiently and permitting rapid visual recovery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19421765     DOI: 10.1007/s00417-009-1097-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  22 in total

1.  A two-stage technique for intraoperative fluid-gas exchange following pars plana vitrectomy.

Authors:  D F Williams; M A Peters; G W Abrams; D P Han; W F Mieler
Journal:  Arch Ophthalmol       Date:  1990-10

2.  Hemostatic effects of SF6 after diabetic vitrectomy for vitreous hemorrhage.

Authors:  C N Koutsandrea; M N Apostolopoulos; D Z Chatzoulis; E A Parikakis; G P Theodossiadis
Journal:  Acta Ophthalmol Scand       Date:  2001-02

3.  Slit-lamp fluid-gas exchange and other office procedures following vitreoretinal surgery.

Authors:  M B Landers; D Robinson; K R Olsen; J Rinkoff
Journal:  Arch Ophthalmol       Date:  1985-07

4.  Management of postvitrectomy diabetic vitreous hemorrhage with tissue plasminogen activator (t-PA) and volume homeostatic fluid-fluid exchanger.

Authors:  W C Wu; S M Chang; J Y Chen; C W Chang
Journal:  J Ocul Pharmacol Ther       Date:  2001-08       Impact factor: 2.671

5.  Vitreous hemorrhage after closed vitrectomy for proliferative diabetic retinopathy.

Authors:  F I Tolentino; V N Cajita; T Gancayco; S Skates
Journal:  Ophthalmology       Date:  1989-10       Impact factor: 12.079

6.  Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications.

Authors:  A P Schachat; R T Oyakawa; R G Michels; T A Rice
Journal:  Ophthalmology       Date:  1983-05       Impact factor: 12.079

7.  Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells.

Authors:  P A Campochiaro; B M Glaser
Journal:  Arch Ophthalmol       Date:  1985-04

8.  Vitreous hemorrhage after vitrectomy for diabetic retinopathy.

Authors:  M A Novak; T A Rice; R G Michels; C Auer
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

9.  Efficacy of fluid-air exchange for postvitrectomy diabetic vitreous hemorrhage.

Authors:  D F Martin; B W McCuen
Journal:  Am J Ophthalmol       Date:  1992-10-15       Impact factor: 5.258

10.  Tissue plasminogen activating factor assisted removal of subretinal hemorrhage.

Authors:  G A Peyman; N C Nelson; W Alturki; K J Blinder; C L Paris; U R Desai; C A Harper
Journal:  Ophthalmic Surg       Date:  1991-10
View more
  1 in total

1.  Visual outcomes and complications following one-way air-fluid exchange technique for vitreous hemorrhage post vitrectomy in proliferative diabetic retinopathy patients.

Authors:  Baojie Hou; Yifei Huang; Qun Wang; Jie Zhao; Qing Xu; Cui Han
Journal:  BMC Ophthalmol       Date:  2021-03-09       Impact factor: 2.209

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.